相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Kristy A. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
Nayana Ghosh-Choudhury et al.
CELLULAR SIGNALLING (2010)
Metformin: A Therapeutic Opportunity in Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Time to Disease Recurrence in Basal-Type Breast Cancers Effects of Tumor Size and Lymph Node Status
Rebecca Dent et al.
CANCER (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Bolin Liu et al.
CELL CYCLE (2009)
Outcome After Breast Conservation Treatment with Radiation for Women with Triple-Negative Early-Stage Invasive Breast Carcinoma
Lawrence J. Solin et al.
CLINICAL BREAST CANCER (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Metformin Inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway
Suman Rice et al.
ENDOCRINOLOGY (2009)
Metformin, insulin, breast cancer and more ...
Lev M. Berstein
FUTURE ONCOLOGY (2009)
Triple Receptor-Negative Breast Cancer: The Effect of Race on Response to Primary Systemic Treatment and Survival Outcomes
Shaheenah Dawood et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
Pamela J. Goodwin et al.
CLINICAL BREAST CANCER (2008)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Targeting AMPK: A new therapeutic opportunity in breast cancer
Sirwan M. Hadad et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation
R. A. Jones et al.
ONCOGENE (2007)
AMP-activated protein kinase in metabolic control and insulin signaling
Mhairi C. Towler et al.
CIRCULATION RESEARCH (2007)
Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxoru bicin-based chemotherapy
Wendy A. Woodward et al.
CANCER (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin - Response to Farooki and Schneider
Samantha L. Bowker et al.
DIABETES CARE (2006)
Increased prevalence of prior breast cancer in women with newly diagnosed diabetes
Lorraine L. Lipscombe et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
Ido Wolf et al.
EUROPEAN JOURNAL OF CANCER (2006)
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
SM Rodríguez-Pinilla et al.
CLINICAL CANCER RESEARCH (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
The potential of antidiabetic thiazolidinediones for anticancer therapy
Andrea Galli et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer
LM Berstein
CANCER LETTERS (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
LC Richardson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mortality from site-specific malignancies in type 2 diabetic patients from Verona
G Verlato et al.
DIABETES CARE (2003)
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis
T Lopez et al.
CANCER CELL (2002)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older
R Yancik et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
